Skip to content

What is the meaning of F75 and F100?

4 min read

According to the World Health Organization (WHO), F75 and F100 are specialized therapeutic milk formulas used in the inpatient treatment of severe acute malnutrition (SAM), particularly in young children. Their names signify their energy density, with F75 providing 75 kcal per 100ml and F100 providing 100 kcal per 100ml. These formulas are part of a two-phased approach designed to safely and effectively rehabilitate malnourished patients.

Quick Summary

F75 and F100 are therapeutic milk formulas for treating severe acute malnutrition under WHO protocols. F75 is used in the initial stabilization phase for 2-7 days, while F100 is for the subsequent rehabilitation or catch-up growth phase. These formulas help manage a patient's delicate metabolic state before promoting rapid weight gain.

Key Points

  • Energy Content is Key: F75 provides 75 kcal/100ml for stabilization, while F100 provides 100 kcal/100ml for rehabilitation.

  • Phased Treatment Protocol: F75 is used in the initial phase to stabilize the patient, and F100 is used in the subsequent phase for catch-up growth.

  • Preventing Refeeding Syndrome: The lower energy and protein density of F75 is crucial for safely starting nutritional therapy without overwhelming a severely malnourished patient.

  • Promoting Catch-Up Growth: The higher nutrient density of F100 is essential for rebuilding wasted tissues and facilitating rapid weight gain once the patient is stable.

  • Context-Dependent Use: Both F75 and F100 are used for inpatient management of severe acute malnutrition (SAM) with medical complications, under strict medical supervision.

In This Article

Understanding the Purpose of F75 and F100

The meanings of F75 and F100 are directly related to their energy content and the specific phase of treatment for severe acute malnutrition (SAM). These therapeutic milks are vital components of the World Health Organization's (WHO) guidelines for managing severe malnutrition in inpatient settings, where patients receive round-the-clock medical supervision. The two-stage protocol is critical for preventing the fatal complication known as refeeding syndrome, which can occur if malnourished patients are given high-energy food too quickly.

The Role of F75 in Stabilization

F75 is the 'starter' formula used during the initial stabilization phase, which typically lasts from 2 to 7 days. The primary goal of this phase is not weight gain but to stabilize the patient's metabolic processes, which have been severely compromised by malnutrition. It is characterized by low protein and sodium content, with a relatively higher proportion of carbohydrates. This composition helps to:

  • Correct electrolyte imbalances, particularly low levels of potassium and magnesium, without overwhelming the patient's system.
  • Slowly re-establish normal metabolism.
  • Address critical conditions like hypoglycaemia, hypothermia, and infection.
  • Introduce nutrition in a carefully controlled manner to avoid complications.

The Role of F100 in Rehabilitation

Once a patient has been stabilized using F75 and their appetite has returned, they are transitioned to F100 for the rehabilitation phase. F100, with its higher energy and protein concentration, is designed to promote rapid weight gain, often called 'catch-up growth'. This phase rebuilds wasted tissues and replenishes the body's energy reserves. The specific composition of F100 allows for:

  • Rapid weight recovery in malnourished children.
  • A higher protein intake to facilitate tissue repair and growth.
  • The safe reintroduction of higher caloric intake under medical supervision.
  • The eventual transition to a standard diet or Ready-to-Use Therapeutic Food (RUTF) for outpatient care.

How F75 and F100 Fit into the Malnutrition Treatment Protocol

The structured use of these two formulas is a cornerstone of the inpatient management of severe acute malnutrition. After an initial assessment and stabilization with F75, the child's progress is carefully monitored. The transition to F100 occurs once the child is clinically stable and begins to show a healthy appetite. After a period of intensive feeding with F100 in the hospital, patients without complications may eventually transition to ready-to-use therapeutic food (RUTF), such as Plumpy'Nut, for continued recovery at home, following updated WHO guidelines. This phased approach is crucial for minimizing mortality and ensuring a successful recovery from the life-threatening condition of SAM.

Comparison of F75 and F100 Therapeutic Formulas

Feature F75 (Stabilization Phase) F100 (Rehabilitation Phase)
Energy Content Lower (75 kcal per 100ml) Higher (100 kcal per 100ml)
Protein Content Lower (0.9 g per 100ml) Higher (2.9 g per 100ml)
Carbohydrate Content Higher relative to protein Lower relative to protein
Sodium Content Lower Higher
Primary Goal Stabilize metabolism, correct electrolyte imbalances Promote rapid weight gain and catch-up growth
Duration Initial 2-7 days Continues for several weeks until recovery
Clinical Status of Patient Medically complicated, potential loss of appetite Clinically stable, good appetite restored

The Development and Impact of Therapeutic Foods

The formulation of F75 and F100 was a significant breakthrough in the treatment of severe malnutrition. Before these standardized protocols, mortality rates for severely malnourished children were alarmingly high. The introduction of these therapeutic milks by aid organizations, following WHO recommendations, dramatically reduced these rates. The formulas are prepared by reconstituting a powdered mix with clean, boiled water, and their use requires strict adherence to hygienic standards to prevent bacterial contamination, especially in challenging field conditions.

In recent years, the development of Ready-to-Use Therapeutic Foods (RUTFs), such as Plumpy'Nut, has further revolutionized malnutrition treatment. Unlike the milk-based formulas that require careful preparation and refrigeration once mixed, RUTFs are lipid-based pastes that are ready to eat, have a long shelf life, and are resistant to microbial contamination. This has enabled the outpatient management of uncomplicated SAM cases, expanding access to life-saving treatment beyond hospital settings. However, F75 and F100 remain essential for the inpatient care of patients with medical complications and unstable conditions.

For more in-depth information on global nutrition protocols, refer to resources from reputable organizations like the World Health Organization (WHO) and UNICEF. For example, UNICEF's technical bulletins provide detailed specifications and safe preparation guidelines for therapeutic milk products like F75 and F100.

Conclusion

In summary, F75 and F100 are not just milk formulas but specific therapeutic tools used in a carefully orchestrated two-phase treatment plan for severe acute malnutrition. The meaning of F75 refers to the stabilization phase, where the focus is on correcting metabolic issues and preparing the body for rehabilitation. In contrast, the meaning of F100 is tied to the subsequent rehabilitation phase, designed for rapid catch-up growth and recovery. Together, they represent a globally standardized and highly effective approach to saving lives and restoring health in severely malnourished populations, as guided by the World Health Organization.

Frequently Asked Questions

The primary difference lies in their energy and protein density, and their intended phase of treatment for severe acute malnutrition (SAM). F75 is lower in energy (75 kcal/100ml) and protein, used for initial stabilization, while F100 is higher in both (100 kcal/100ml) for the rehabilitation and weight-gain phase.

F75 is used during the initial or stabilization phase of treatment for severe acute malnutrition (SAM). This phase focuses on correcting metabolic and electrolyte imbalances before the body can safely handle more energy and protein.

F75 is used first to prevent refeeding syndrome, a potentially fatal complication that can occur when a severely malnourished body is given a high caloric load too quickly. The lower energy density of F75 allows for a gradual and safe re-introduction of nutrients.

No, F100 should not be used for initial treatment. It is too high in energy and protein for the delicate metabolic state of a newly admitted, severely malnourished patient and could cause refeeding syndrome.

F75 and F100 are specifically designed and indicated for the inpatient treatment of severe acute malnutrition (SAM) with medical complications. They are not intended for general long-term feeding of well-nourished children or milder cases of malnutrition.

After successful treatment with F100 in an inpatient setting, patients often transition to a Ready-to-Use Therapeutic Food (RUTF), such as Plumpy'Nut, for continued recovery at home. This allows for a smooth transition back to a normal diet.

The World Health Organization (WHO) developed and standardized the protocols for using F75 and F100 in the management of severe malnutrition.

References

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6

Medical Disclaimer

This content is for informational purposes only and should not replace professional medical advice.